当前位置: 首页 >> 检索结果
共有 303 条符合本次的查询结果, 用时 1.6730225 秒

261. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines.

作者: Andrew L Ries.;Gerene S Bauldoff.;Brian W Carlin.;Richard Casaburi.;Charles F Emery.;Donald A Mahler.;Barry Make.;Carolyn L Rochester.;Richard Zuwallack.;Carla Herrerias.
来源: Chest. 2007年131卷5 Suppl期4S-42S页
Pulmonary rehabilitation has become a standard of care for patients with chronic lung diseases. This document provides a systematic, evidence-based review of the pulmonary rehabilitation literature that updates the 1997 guidelines published by the American College of Chest Physicians (ACCP) and the American Association of Cardiovascular and Pulmonary Rehabilitation.

262. Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis.

作者: Jing Jiang.;Huan-Zhong Shi.;Qiu-Li Liang.;Shou-Ming Qin.;Xue-Jun Qin.
来源: Chest. 2007年131卷4期1133-41页
Conventional tests are not always helpful in making a diagnosis of tuberculous pleurisy. Many studies have investigated the usefulness of interferon (IFN)-gamma measurements in pleural fluid for the early diagnosis of tuberculous pleurisy. We conducted a metaanalysis to determine the accuracy of IFN-gamma measurements in the diagnosis of tuberculous pleurisy.

263. A systematic review of the diagnosis of occupational asthma.

作者: Jeremy Beach.;Kelly Russell.;Sandra Blitz.;Nicola Hooton.;Carol Spooner.;Catherine Lemiere.;Susan M Tarlo.;Brian H Rowe.
来源: Chest. 2007年131卷2期569-78页
This study systematically reviews literature regarding the diagnosis of occupational asthma (OA) and compares specific inhalation challenge (SIC) testing with alternative tests.

264. Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: A systematic review and metaanalysis.

作者: Carlos G Micames.;Douglas C McCrory.;Darren A Pavey.;Paul S Jowell.;Frank G Gress.
来源: Chest. 2007年131卷2期539-48页
Endoscopic ultrasound (EUS)-guided fine-needle aspiration (FNA) is a minimally invasive alternative technique for mediastinal staging of non-small cell lung cancer. A metaanalysis was performed to estimate the diagnostic accuracy of EUS-FNA for staging mediastinal lymph nodes (N2/N3 disease) in patients with lung cancer.

265. A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD.

作者: Judy M Bradley.;Toby Lasserson.;Stuart Elborn.;Joe Macmahon.;Brenda O'neill.
来源: Chest. 2007年131卷1期278-85页
To systematically review the short-term efficacy of ambulatory oxygen from single-assessment studies in COPD.

266. Respiratory physiotherapy to prevent pulmonary complications after abdominal surgery: a systematic review.

作者: Patrick Pasquina.;Martin R Tramèr.;Jean-Max Granier.;Bernhard Walder.
来源: Chest. 2006年130卷6期1887-99页
To examine the efficacy of respiratory physiotherapy for prevention of pulmonary complications after abdominal surgery.

267. Effect of study setting on anticoagulation control: a systematic review and metaregression.

作者: Carl van Walraven.;Alison Jennings.;Natalie Oake.;Dean Fergusson.;Alan J Forster.
来源: Chest. 2006年129卷5期1155-66页
For patients receiving therapy with oral anticoagulants (OACs), the proportion of time spent in the therapeutic range (ie, anticoagulation control) is strongly associated with bleeding and thromboembolic risk. The effect of study-level factors, especially study setting, on anticoagulation control is unknown.

268. Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis.

作者: Fawziah Marra.;Larry Lynd.;Megan Coombes.;Kathryn Richardson.;Michael Legal.;J Mark Fitzgerald.;Carlo A Marra.
来源: Chest. 2006年129卷3期610-8页
To determine the association between antibiotic exposure in the first year of life and the development of childhood asthma.

269. Guidelines for evaluating chronic cough in pediatrics: ACCP evidence-based clinical practice guidelines.

作者: Anne B Chang.;William B Glomb.
来源: Chest. 2006年129卷1 Suppl期260S-283S页
To review relevant literature and present evidence-based guidelines to assist general and specialist medical practitioners in the evaluation and management of children who present with chronic cough.

270. Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines.

作者: F Dennis McCool.;Mark J Rosen.
来源: Chest. 2006年129卷1 Suppl期250S-259S页
Airway clearance may be impaired in disorders associated with abnormal cough mechanics, altered mucus rheology, altered mucociliary clearance, or structural airway defects. A variety of interventions are used to enhance airway clearance with the goal of improving lung mechanics and gas exchange, and preventing atelectasis and infection.

271. Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review.

作者: Mathilde Nijkeuter.;Marcel M C Hovens.;Bruce L Davidson.;Menno V Huisman.
来源: Chest. 2006年129卷1期192-7页
Much attention has been paid in recent years to optimizing the diagnosis of acute pulmonary embolism (PE). However, little is known about the changes in clot burden that occur at the level of the pulmonary arteries after documented PE. It is often problematic to distinguish between a new or residual defect on lung scintigraphy or helical CT. This may lead to falsely labeling patients with residual PE as having recurrent PE and consequent unnecessary treatment changes.

272. Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force.

作者: Gordon Guyatt.;Michael Baumann.;Stephen Pauker.;Jonathan Halperin.;Janet Maurer.;Douglas K Owens.;Anna N A Tosteson.;Brian Carlin.;David Gutterman.;Martin Prins.;Sandra Zelman Lewis.;Holger Schünemann.
来源: Chest. 2006年129卷1期182-7页
Most panels that develop clinical practice guidelines are poorly equipped to address resource allocation or cost issues associated with management options. This risks neglect, arbitrariness, lack of transparency, and methodological flaws in consideration of resource allocation. We provide recommendations for guideline panels to promote greater transparency and rigor. We suggest focusing on resource allocation issues for only a limited number of recommendations and provide criteria for selecting those in which economic considerations are likely to influence the direction or strength of the recommendation. Panels should involve a health economist to assist with the systematic review and critical interpretation of relevant economic analyses. They should carefully define the intended audience and may consider issuing alternative recommendations when available resources vary widely across target clinical settings. Targeting a limited number of recommendations for the consideration of resource allocation issues, and ensuring methodologically high-quality review, will best serve guideline panels, and the health-care providers and patients they hope to assist.

273. Long-acting bronchodilator or leukotriene modifier as add-on therapy to inhaled corticosteroids in persistent asthma?

作者: Graeme P Currie.;Daniel K C Lee.;Prasima Srivastava.
来源: Chest. 2005年128卷4期2954-62页
Despite the widespread use of inhaled corticosteroids, many asthmatic patients experience persistent symptoms. In such individuals, the addition of a long-acting beta2-agonist (LABA) is frequently more effective than doubling the dose of inhaled corticosteroid. However, the role of additional therapy with a leukotriene receptor antagonist (LTRA) as an alternative to an LABA has been the focus of attention in recent studies. In order to determine the overall efficacy of the pharmacologic armamentarium used in asthma, it is imperative that a combination of end points, including lung function, airway hyperresponsiveness, effects on underlying inflammation, symptoms, and more long-term sequelae such as exacerbations, are assessed. This evidence-based systematic review outlines the pharmacologic properties of LABAs and LTRAs and the importance of evaluating end points in addition to lung function when assessing these drugs. We also highlight the results of all published studies that have performed direct comparisons of both LABAs and LTRAs as add-on therapy to inhaled corticosteroids.

274. Intraoperative interventions: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery.

作者: Lawrence L Creswell.;John C Alexander.;T Bruce Ferguson.;Alan Lisbon.;Lee A Fleisher.; .
来源: Chest. 2005年128卷2 Suppl期28S-35S页
A comprehensive evidence review was conducted of the medical literature regarding the relationship between intraoperative interventions and the incidence of postoperative atrial arrhythmias, including, most commonly, atrial fibrillation (AF). Fifteen randomized, controlled studies and one large-scale concurrent cohort study were identified that reported on the following issues: systemic temperature during surgery (one report); "beating heart" surgery vs conventional bypass surgery (three reports); type of myocardial protection (five reports); the use of adjunctive posterior pericardiotomy (one report); the use of thoracic epidural anesthesia (TEA) [two reports]; the use of glucose-insulin-potassium (GIK) solutions (two reports); and the use of heparin-coated circuits for cardiopulmonary bypass (CPB) [two reports]. Based on a systematic review of the reported data and an analysis of the quality of the reported data, we recommend the following: (1) that mild hypothermia, rather than moderate hypothermia, may be effective in reducing the frequency of postoperative AF; (2) the use of posterior pericardiotomy may be a useful adjunct to reduce the frequency of postoperative AF; and (3) the use of heparin-coated CPB circuits is associated with less postoperative AF. Because of conflicting or inadequate data, we cannot conclude that the frequency of postoperative AF is affected by (1) the use of beating-heart techniques, (2) the type of myocardial protection strategy used, (3) the use of TEA, or (4) the use of GIK solutions perioperatively.

275. Aerosolized magnesium sulfate for acute asthma: a systematic review.

作者: Maurice Blitz.;Sandra Blitz.;Rodney Hughes.;Barry Diner.;Richard Beasley.;Jennifer Knopp.;Brian H Rowe.
来源: Chest. 2005年128卷1期337-44页
The use of MgSO(4) is one of numerous treatment options available during exacerbations of asthma. While the efficacy of therapy with IV MgSO(4) has been demonstrated, little is known about inhaled MgSO(4).

276. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature.

作者: Don D Sin.;LieLing Wu.;S F Paul Man.
来源: Chest. 2005年127卷6期1952-9页
Conditions that give rise to reduced lung function are frequently associated with low-grade systemic inflammation, which may lead to poor cardiovascular outcomes. We sought to determine the relationship between reduced FEV1 and cardiovascular mortality, independent of smoking.

277. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.

作者: Myrna B Dolovich.;Richard C Ahrens.;Dean R Hess.;Paula Anderson.;Rajiv Dhand.;Joseph L Rau.;Gerald C Smaldone.;Gordon Guyatt.; .; .
来源: Chest. 2005年127卷1期335-71页
The proliferation of inhaler devices has resulted in a confusing number of choices for clinicians who are selecting a delivery device for aerosol therapy. There are advantages and disadvantages associated with each device category. Evidence-based guidelines for the selection of the appropriate aerosol delivery device in specific clinical settings are needed.

278. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis.

作者: Matthew W Reynolds.;Kyle Fahrbach.;Ole Hauch.;Gail Wygant.;Rhonda Estok.;Catherine Cella.;Luba Nalysnyk.
来源: Chest. 2004年126卷6期1938-45页
To examine the relationship between international normalized ratio (INR) and outcomes (major bleeding events and strokes) in patients with atrial fibrillation (AF) receiving anticoagulation with warfarin.

279. Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review.

作者: Claudia Steurer-Stey.;Lucas M Bachmann.;Johann Steurer.;Martin R Tramèr.
来源: Chest. 2004年126卷5期1645-55页
Oral lyophilized extracts of bacteria species have been used since the early 1970s to improve symptoms and to prevent exacerbations in COPD patients. The value of these treatments, which are thought to be immunomodulating, is poorly understood. Our aim was to quantify the efficacy of oral bacteria extracts in patients with chronic bronchitis and COPD.

280. Peripheral muscle strength training in COPD: a systematic review.

作者: Simone D O'Shea.;Nicholas F Taylor.;Jennifer Paratz.
来源: Chest. 2004年126卷3期903-14页
Skeletal muscle weakness, and the associated impact on exercise tolerance, provides a strong theoretical rationale for strength training intervention for people with COPD.
共有 303 条符合本次的查询结果, 用时 1.6730225 秒